Background : Severe burns are among the commonly occurring trauma with lethal outcome. One of the important aspects of severe burn therapy is to quickly achieve wound healing. Previous reports indicated that mesenchymal stem cells (MSCs) therapy contributes in facilitating better wound healing. In this report, we investigated the effects of MSCs derived from human bone marrow and umbilical cord on wound healing in patients with severe burns and its mechanism.
INTRODUCTION
Severe burns are among the commonly occurring trauma with lethal outcome. One of the important aspects of severe burn therapy is to quickly achieve wound healing. Previous reports indicated that mesenchymal stem cells (MSCs) therapy contributes in facilitating better wound healing. In this report, we investigated the effects of MSCs derived from human bone marrow and umbilical cord on wound healing in patients with severe burns and its mechanism.
CASE REPORT
We performed human bone marrow and human umbilical cord MSCs therapy on 3 severe burns patients. Two of the patients had inadequate donor to close raw surface with skin graft, whilst one patient had infected chronic burn wound which have failed to epithelize despite repeated attempts of skin graft and wound care. The human umbilical cord-mesenchymal stem cell was applied to the patient for an alternative therapy to achieve wound closure.
Case 1: 51 years old female. She had infected chronic burn wound, she previously suffered tburn injury grade II and III about 35 % total body surface area due to fire. In the span of 1 year she had repeated skin graft procedure and wound care, unfortunately the wound failed to achieve epithelialization. The wound was exudative and had secondary infection. We decided to try the application of mesenchymal stem cells therapy to the wound, and there was notable progress in reduced exudates and the epithelialization started to cover the raw surface. Case 2: 35 years old female. This patient had burn injury grade II and III about 36,5 % total body surface area due to fire. She had inadequate donor to close the defect with skin graft, and we performed mesenchymal stem cells therapy to the wound.
The result observed after therapy was that the advancement of the epithelialization from margin to the raw surface was faster from the other region of the body treated with standard therapy. Case 3: 13 years old male. He had burn injury grade II and III, about 41,5 % % total body surface due to fire. This patient also had inadequate donor to close the defect with skin graft, and we also performed mesenchymal stem cells therapy to the wound. The result was the advancement of epithelialization from margin to the raw surface was also faster from the other region of the body treated with standard therapy as observed in case 2.
A B
C D E DISCUSSION
Cell therapy has been used to treat burns since the introduction of composite epithelial autografts (CEA) by Green in 1975, evolving to dermal substitutes, later on to dermal-epidermal bio-engineered cultured skin substitutes and eventually to stem cells.(1) Stem cell therapy after burn injury emerges as a promising treatment strategy, not only for wound healing, but also to treat systemic effects of burn trauma, the hyper metabolic response, inflammation (e.g., inflammatory-related diseases, such as acute lung injury/respiratory distress syndrome), and immunosuppression. (2) Stem cell therapy may offer an alternative to large volume resuscitation and be an adjunct to lung-protective ventilation strategies after severe burn injury 3. Paracrine mechanisms and growth factor secretion, rather than post-engraftment differentiation and proliferation, seem to predominate in therapeutic effects of MSCs . Corresponding author : Aditya Wardhana aditya_wrdn@yahoo.com gene delivery with stem cell therapy appears promising (6) . Gene therapy involves the insertion of a gene into recipient cells by viral transfection, naked DNA application, high pressure injection or liposomal vectors (7) . Sequential growth factor gene therapy delivers a cocktail of growth factor genes at strategic time points of wound healing. (8) Promising results were revealed in this study, in the form of increased epithelialization rate of the burn wounds after application of MSCs therapy, even in a previously infected wound. However, in follow up, unfavorable scars occurred in 2 patients. Apparently, MSCs couldn't inhibit the occurrence of hypertrophic scar. Further researches are still needed on the role of MSCs in wound healing on the complex burn injury.
CONCLUSION
This study suggests that MSCs can effectively improve wound healing in severe burns patients. Unfortunately, hypertrophic scars developed in the two patients couldn't be avoided as it is among the common burns complications.
